Clinical Trial Update: The 10-Year Extended Follow-up of the DACAB Trial

View source ↗

Summary

An update on the 10-year extended follow-up of the DACAB trial in patients with coronary artery disease undergoing coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Ruijin Hospital | Conditions: Coronary Artery Disease, CABG | Status: ENROLLING_BY_INVITATION